Emergency medicine Australasia : EMA
-
Emerg Med Australas · Jun 2020
Informing Emergency Care for COVID-19 patients: The COVID-19 Emergency Department (COVED) Quality Improvement Project Protocol.
There is an urgency to support Australian ED clinicians with real-time tools as the COVID-19 pandemic evolves. The COVID-19 Emergency Department (COVED) Quality Improvement Project has commenced and will provide flexible and responsive clinical tools to determine the predictors of key ED-relevant clinical outcomes. ⋯ This project will support EDs during this pandemic.
-
Emerg Med Australas · Jun 2020
Consumer involvement in emergency medicine research: Lessons from engaging sepsis survivors.
Collaboration with consumers is an emerging focus for medical researchers worldwide. Public involvement is increasingly encouraged, and in some cases stipulated by funding bodies, in order to secure financial support. While consumer involvement could be viewed as another hurdle in the funding application process, it can add immense value to research outcomes. However, given the diverse and transient nature of our consumer group, how can we develop meaningful public engagement in emergency medicine research?
-
Emerg Med Australas · Jun 2020
Restrictive interventions in Victorian emergency departments: A study of current clinical practice.
To determine current clinical practices for managing behavioural emergencies within Victorian public hospital EDs. ⋯ Restrictive interventions in the ED largely occurred under a Duty of Care. Care of patients managed under legislation that covers assessment and treatment of mental illness has a strong clinical governance framework and focus on minimising restrictive interventions. However, this is not applied to the majority of patients who experience restraint in Victorian EDs.
-
Emerg Med Australas · Jun 2020
Observational StudyPrevalence of illicit substance use among patients presenting to the emergency department with acute behavioural disturbance: Rapid point-of-care saliva screening.
To determine the prevalence of illicit substance use among patients presenting to one ED with acute behavioural disturbance using point-of-care saliva testing. ⋯ The prevalence of illicit substance use among this cohort was 40%. Self-reporting was unreliable. Point-of-care saliva testing is feasible. Early identification of harmful drug use may assist clinical decision making in selected or undifferentiated cases and provide an opportunity to implement harm minimisation strategies and make referrals.